Dynamic regulation of EZH2 from HPSc to hepatocyte-like cell fate

PloS One
Mariaelena PistoniCatherine M Verfaillie

Abstract

Currently, drug metabolization and toxicity studies rely on the use of primary human hepatocytes and hepatoma cell lines, which both have conceivable limitations. Human pluripotent stem cell (hPSC)-derived hepatocyte-like cells (HLCs) are an alternative and valuable source of hepatocytes that can overcome these limitations. EZH2 (enhancer of zeste homolog 2), a transcriptional repressor of the polycomb repressive complex 2 (PRC2), may play an important role in hepatocyte development, but its role during in vitro hPSC-HLC differentiation has not yet been assessed. We here demonstrate dynamic regulation of EZH2 during hepatic differentiation of hPSC. To enhance EZH2 expression, we inducibly overexpressed EZH2 between d0 and d8, demonstrating a significant improvement in definitive endoderm formation, and improved generation of HLCs. Despite induction of EZH2 overexpression until d8, EZH2 transcript and protein levels decreased from d4 onwards, which might be caused by expression of microRNAs predicted to inhibit EZH2 expression. In conclusion, our studies demonstrate that EZH2 plays a role in endoderm formation and hepatocyte differentiation, but its expression is tightly post-transcriptionally regulated during this process.

References

Nov 6, 1998·Science·J A ThomsonJ M Jones
Aug 3, 2002·Science·György Hutvágner, Phillip D Zamore
Oct 15, 2005·Development·Ines Alvarez-Garcia, Eric A Miska
Mar 7, 2007·Molecular and Cellular Biology·Diego PasiniKristian Helin
Oct 22, 2008·Nature Cell Biology·Klaus H HansenKristian Helin
Oct 29, 2008·Genome Research·Robin C FriedmanDavid P Bartel
Nov 15, 2008·Science·Sooryanarayana VaramballyArul M Chinnaiyan
May 21, 2010·Stem Cell Research·Melissa A BaxterNeil A Hanley
Jul 14, 2010·Cell Stem Cell·Kathryn N Ivey, Deepak Srivastava
Sep 2, 2010·Cell Stem Cell·Lauren E SurfaceLaurie A Boyer
Sep 2, 2010·Cell Stem Cell·Martin Sauvageau, Guy Sauvageau
Oct 27, 2010·The Journal of Experimental Medicine·Nicolaj Strøyer Christophersen, Kristian Helin
Jan 21, 2011·Nature·Raphaël Margueron, Danny Reinberg
Jan 29, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Nury KimYong-Mahn Han
Apr 24, 2012·Journal of Hepatology·Philip RoelandtCatherine M Verfaillie
Sep 25, 2012·International Journal of Cancer. Journal International Du Cancer·Leonidas BenetatosEleftheria Hatzimichael
Jan 9, 2013·Annual Review of Pharmacology and Toxicology·Dagmara SzkolnickaDavid C Hay
Jan 25, 2013·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Huijun ZhangKe Fei
Feb 22, 2013·Nature Protocols·Nicholas R F HannanLudovic Vallier
Jun 4, 2013·Nature Chemical Biology·Jing ShanSangeeta N Bhatia
Jan 28, 2014·PloS One·Richard L GieseckLudovic Vallier
Feb 13, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Yemiao Chen, Catherine M Verfaillie
Feb 15, 2014·Molecular Cancer Research : MCR·Gauri DebSanjay Gupta
Nov 12, 2014·Expert Opinion on Drug Metabolism & Toxicology·David A Mann
Nov 26, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dustin R BergerSalman R Khetani
May 6, 2015·Stem Cell Reports·Richard SillerGareth J Sullivan
Dec 3, 2015·Journal of Hepatology·Nicky HelsenCatherine M Verfaillie
Sep 23, 2016·Schweizer Archiv für Tierheilkunde·U BraunM Hässig

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
reverse-transcription PCR
PCR
immunoprecipitation
FACS
ELISA
transgenic

Software Mentioned

Axiovision
QUMA
FACS Diva

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.